| Applications |
The 28-2-7 (ATCC CRL-2487) and 28-6-20 (ATCC CRL-2489) antibodies bind the V kappa 24 light chain idiotypic specificity of MOPC167. MOPC167 is an IgA myeloma specific for PC and HPCM27 is an IgM myeloma specific for PC. The antibodies are specific for PC-binding proteins of VH1/V kappa 24 heavy and light chains of various isotypes. These antibodies can be used as typing reagents for mouse IgA bearing the V kappa 24 idiotypic specificity. They can be used in typing the 207-4 immunoglobulin transgenic mice that carry the VH1/V kappa 24 gene segment of the IgA PC specific MOPC167 myeloma. |
| Comments |
The 28-2-7 (ATCC CRL-2487) and 28-6-20 (ATCC CRL-2489) antibodies bind the V kappa 24 light chain idiotypic specificity of MOPC167. Animals were immunized with MOPC167 and HPCM27 anti-phosphocholine (PC) antibodies. MOPC167 is an IgA myeloma specific for PC and HPCM27 is an IgM myeloma specific for PC. Spleen cells were fused with P3X63Ag8.653 mouse myeloma cells. The antibodies are specific for PC-binding proteins of VH1/V kappa 24 heavy and light chains of various isotypes. They do not bind VH1/V kappa 22, VH1/V kappa 8, or VH1/V kappa 1 PC-binding proteins or other IgA or IgM myeloma proteins. These antibodies can be used as typing reagents for mouse IgA bearing the V kappa 24 idiotypic specificity. They can be used in typing the 207-4 immunoglobulin transgenic mice that carry the VH1/V kappa 24 gene segment of the IgA PC specific MOPC167 myeloma. |
| References |
Sieckmann DG, et al. Anti-idiotype monoclonal antibodies specific for the MOPC167 anti-phosphocholine transgene-encoded antibody. Hybridoma 16: 503-511, 1997. PubMed: 9455702
Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC.
Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988.
Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC.
Biosafety in Microbiological and Biomedical Laboratories, 5th ed. HHS. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Washington DC: U.S. Government Printing Office; 2007. The entire text is available online.
|
